Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of GW406381 on methotrexate pharmacokinetics in rheumatoid arthritis
2004-000106-41Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of GW406381 in rheumatoid arthritis (RA), sponsored by GSK. Primary endpoints: Methotrexate AUC(0-24) without and with GW406381 and Methotrexate Cmax without and with GW406381. Started Aug 2004; status: completed.
02
Drugs
GW406381
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2004-000106-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000106-41.